Humana is a leading health insurance company that provides a wide range of health and wellness solutions to individuals, families, and employers. The organization offers Medicare Advantage plans, Medicaid services, and individual health insurance policies, focusing on enhancing the health and well-being of its members. Additionally, Humana invests in technology and innovative care management services, aiming to improve healthcare delivery and patient outcomes. The company is dedicated to integrating medical and wellness services to create a comprehensive approach to health management for its customers. Read More
Shares of health insurance company Humana (NYSE:HUM)
fell 3.8% in the afternoon session after the company lost a key lawsuit aimed at reversing cuts to Medicare bonus payments and received a new "sell" rating from Goldman Sachs.
Wall Street edged higher Tuesday as strong bank earnings lifted sentiment, even as renewed U.S.-China trade tensions kept investor enthusiasm in check.
Bloomberg reported on Tuesday that a Texas judge ruled in favor of the federal government, affirming a downgrade of quality ratings that are tied to payments for Medicare Advantage.
Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.
The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 44 years, today announced its ambition to become a national leader in addressing seniors’ emotional health. More than one in four seniors (29%) report being socially isolated, increasing their risk of dementia (by 50%) and self-harm. The Foundation’s 2025 program and research grants—totaling over $12 million—tackle loneliness, illness and other community and cultural drivers of poor emotional health with interventions tested regionally and deployed nationwide.
Humana Inc. (NYSE: HUM) will release its financial results for the third quarter 2025 (3Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on November 5, 2025. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2025.
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Friday to find the gap up and gap down stocks in today's session.
October 9, 2025 - Duos, a digital health company dedicated to empowering older adults to live independently, today announced a monumental $130 million strategic growth equity investment. This substantial funding round, spearheaded by FTV Capital with additional participation from early institutional investor Forerunner Ventures, marks a pivotal moment for the
Bragar Eagel & Squire, P.C. Litigation Attorney Brandon Walker Encourages Investors Who Suffered Losses In Humana (HUM) To Contact Him Directly To Discuss Their Options
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Monday. Discover which stocks are leading as top gainers and losers in today's session.
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
As the S&P 500 navigates a dynamic market on October 3, 2025, the Healthcare sector has emerged as a steadfast performer, demonstrating remarkable resilience and contributing significantly to the overall market's strength. This stability comes at a crucial time, as the technology sector experiences a notable pullback, leading investors
New York, NY – October 3, 2025 – While market reports today, October 3, 2025, show UnitedHealth Group (NYSE: UNH) as a top performer in the Dow Jones Industrial Average, with shares gaining approximately 1.5% and extending a five-day winning streak, a closer examination reveals a more complex narrative. Despite this
